Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition

Autor: Chan, Susan, Fox, Adam, Abraham, Mable, Adam, Muhsinah, Clough, Lyn, Coverdale, Louise, Fisher, Helen, Henley, Fiona, Hussain, Saadia, Johnston, Victoria, Nixon, Amy, O'Dwyer-Leeson, Una, Sheridan, Aine, Amarra, Tammy, Cockerell, Kathryn, Lacey, Sarah, Harland, Gail, Stedman, Charlotte, Towell, Ruth, Basting, Monica, Clarke, Catherine, Cleaver, Richard, Deutsch, Gemma, Harris, Erica, Nirenstein, Lori, Parr, Alicia, Becares, Natalia, Crossley, Matthew, do Couto Francisco, Natalia, Richards, Kerry, Patel, Deeviya, Pietraszewicz, Ewa, Stephens, Alick, Sudra, Asha, Wester, Rianne, Wilson, Alastair, Wu, Celine, Heath, Jenna, Hersee, Kathryn, Patkunam, Devi, Adamkiewicz, Michael, Asare, Adam, Chani, Eduard, Evind, Judith, Harris, Kristina, Lim, Noha, Nasser, Nariman, Plough, Audrey, Romaine, Jennifer, Stahly, Michael, Panza, Joy Laurienzo, McCachren, Susan, Mason, Travis, Nelson, Valerie, Feeney, Mary, Du Toit, George, Roberts, Graham, Sayre, Peter H., Lawson, Kaitie, Bahnson, Henry T., Sever, Michelle L., Radulovic, Suzana, Plaut, Marshall, Lack, Gideon

Publikováno v: In The Journal of Allergy and Clinical Immunology October 2016 138(4):1108-1118

Randomized controlled trial of atorvastatin in clinically isolated syndrome: The STAyCIS study

Autor: Waubant, E., Pelletier, D., Mass, M., Cohen, J.A., Kita, M., Cross, A., Bar-Or, A., Vollmer, T., Racke, M., Stüve, O., Schwid, S., Goodman, A., Kachuck, N., Preiningerova, J., Weinstock-Guttman, B., Calabresi, P.A., Miller, A., Mokhtarani, M., Iklé, D., Murphy, S., Kopetskie, H., Ding, L., Rosenberg, E., Spencer, C., Zamvil, S.S., Bourdette, D., Egan, R., Cohen, J., Stone, L., Elliott, M., Parks, B.J., Campagnolo, D., Frohman, E., Segal, B., Weiner, L., Carrithers, M., Calabresi, P., Kerr, D., Lublin, F., Sayre, Peter, Hayes, Deborah, Rosenberg, Ellen, Gao, Wendy, Ding, Linna, Adah, Steven, Mokhtarani, Masoud, Neuenburg, Jutta, Bromstead, Carolyn, Olinger, Lynn, Mullen, Blair, Jamison, Ross, Speth, Kelly, Saljooqi, Kerensa, Phan, Peter, Phippard, Deborah, Seyfert-Margolis, Vicki, Bourcier, Katarzyna, Debnam, Tracia, Romaine, Jennifer, Wolin, Stephanie, O'Dale, Brittany, Iklé, David, Murphy, Stacey, Kopetskie, Heather

Objective: To test efficacy and safety of atorvastatin in subjects with clinically isolated syndrome (CIS). Methods: Subjects with CIS were enrolled in a phase II, double-blind, placebo-controlled, 14-center randomized trial testing 80 mg atorvastati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5597b9113aaf8aeb75b84ec355b56f
https://europepmc.org/articles/PMC3320055/